Cipla Ltd.: Clinical Trials

2 trials sponsored by Cipla Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 suspended. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Suspended 1
Phase 31Completed 1

Follow Cipla Ltd.: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV
Pramipexole ER, Escitalopram - Major Depressive Disorder, Mild Neurocognitive Disorder
Phase 2SuspendedNational Institute of Allergy and Infectious Diseases (NIAID)1862026-05-172026-07-14
Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis
Prednisolone, Voriconazole - Allergic Bronchopulmonary Aspergillosis
Phase 2 / Phase 3CompletedPost Graduate Institute of Medical Education and Research, Chandigarh502013-06-012017-12-12

Conditions studied

Aspergillosis, Allergic Bronchopulmonary (1)  ·  Depressive Disorder, Major (1)  ·  Neurocognitive Disorders (1)

Interventions

Escitalopram (1)  ·  Prednisolone (1)  ·  Voriconazole (1)

Countries

India (2)  ·  Botswana (1)  ·  Brazil (1)  ·  Kenya (1)  ·  Malawi (1)  ·  Mexico (1)  ·  Peru (1)  ·  Philippines (1)  ·  South Africa (1)  ·  Thailand (1)  ·  Uganda (1)  ·  United States (1)  ·  Vietnam (1)  ·  Zimbabwe (1)

Top investigators

Scott Letendre, MD (1)  ·  William R Short, MD (1)

Results publications

PMID 30049743